Rituximab-treated patients have a poor response to influenza vaccination. [electronic resource]
Producer: 20130802Description: 388-96 p. digitalISSN:- 1573-2592
- Adult
- Aged
- Antibodies, Monoclonal, Murine-Derived -- adverse effects
- Antibodies, Viral -- immunology
- Antigens, CD19 -- metabolism
- Antirheumatic Agents -- adverse effects
- B-Lymphocytes -- drug effects
- Female
- Humans
- Immunity, Humoral -- drug effects
- Immunoglobulin G -- immunology
- Immunologic Memory
- Influenza Vaccines -- administration & dosage
- Influenza, Human -- prevention & control
- Lymphocyte Count
- Lymphocyte Depletion
- Male
- Middle Aged
- Rheumatic Diseases -- drug therapy
- Rituximab
- T-Lymphocyte Subsets -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.